Search results
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 24 hours agoThe patents are registered with the Food and Drug Administration, which reviews and approves new...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition - WTOP News
WTOP Washington· 1 day agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration ...
J&J, Bristol Myers lose challenges to US drug price negotiation program By Reuters
Investing.com· 2 days ago"In short, defendants are not taking drugs from plaintiffs," Quraishi wrote, adding that they were...
The US Presidents Who Added the Most to the National Debt
247wallst.com· 5 days agoThe federal government of the United States has carried some level of debt every year since George...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KOLR - KSFX Ozarks· 1 day agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters· 2 days ago, opens new tab to a law requiring them to negotiate the prices of their blockbuster blood clot...
President Biden scraps 'Bidenomics' after slogan falls flat
USA Today· 5 days agoWASHINGTON ― Last June, in what the White House envisioned would be a turning-point speech in...
Whatever Happened to Biden’s Public Option?
North Denver News· 6 days agoIn the 2020 elections, then-candidate Joe Biden and many of his congressional colleagues loudly advocated for a federal “public option” health insurance ...
Should the presidential debate remain televised? America is tired of unproductive rants.
Gannett via AOL· 6 days agoIt would be good for the country if Biden and Trump could seriously discuss the future of Social...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 1 day agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...